Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 4,601–4,603 of 4,603 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02498756	Cytokine-induced Killer Study for Patients With Stage II Melanoma	not yet recruiting	Phase 2	300	The First People's Hospital of ChangzhouOTHER	0	Jul 15, 2015	clinicaltrials
NCT02490735	CIK in Treating Patients With Esophageal Cancer	not yet recruiting	Phase 2	2,000	The First People's Hospital of ChangzhouOTHER	0	Jul 7, 2015	clinicaltrials